Evidence map›Paper›PMID 29531130›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018

Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study.

Brian Z Ring, Rajmohan Murali, Robert A Soslow, David D L Bowtell, Sian Fereday, Anna deFazio, Nadia Traficante, Catherine J Kennedy, Alison Brand, Raghwa Sharma and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Brian Z RingInstitute of Personalized and Genomic Medicine, College of Life Science, Huazhong University of Science and Technology, Wuhan, China.
Rajmohan MuraliDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-6988-4295
Robert A SoslowDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
David D L BowtellPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sian FeredayPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Anna deFazioCentre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
Nadia Traficante
Catherine J KennedyCentre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
Alison BrandDepartment of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
Raghwa SharmaThe University of Sydney, Sydney, New South Wales, Australia.
Paul HarnettCentre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
Goli SamimiDivision of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland. goli.samimi@nih.gov.
Australian Ovarian Cancer Study
The University of Sydney · AUPeter MacCallum Cancer Centre · AUMemorial Sloan Kettering Cancer Center · USHuazhong University of Science and Technology · CNNational Cancer Institute · USWestmead Hospital · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Intramural NIH HHS Z99 CA999999NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bridged-Ring CompoundsCohort StudiesCo-Repressor ProteinsFemaleHumansOvarian NeoplasmsSurvival RateTaxoidsBridged-Ring CompoundsCo-Repressor ProteinstaxaneTaxoidsTLE3 protein, human

Identifiers

PMID29531130
PMCPMC5984690
OpenAlexW2793281175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.